Surrey researchers Sign in
Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia
Journal article

Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia

M Shahmanesh, S Das, M Stolinski, F Shojaee-Moradie, NC Jackson, W Jefferson, R Cramb, P Nightingale and AM Umpleby
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Vol.90(2), pp.755-760
01/02/2005

Abstract

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism ENDOCRINOLOGY & METABOLISM REVERSE-TRANSCRIPTASE INHIBITORS INSULIN-RESISTANCE METABOLIC ABNORMALITIES CARDIOVASCULAR-DISEASE FAT DISTRIBUTION HIV-INFECTION CELL FUNCTION RISK-FACTORS APO-B THERAPY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000226850700025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy